Biomarkers of Cognitive Impairment in Blood Cells

The aim of this study is to identify transcriptomic biomarkers in blood cells to diagnose early cognitive impairment. This would allow preventing the development of severe pathologies, such as Alzheim...

Lead sponsor: University of the Balearic Islands•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

Active Not RecruitingPhase 2

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

NCT05399888 · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

UNKNOWNPhase 2

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

NCT04141150 · Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, and more

TERMINATEDPhase 3

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

NCT02284906 · Mild Cognitive Impairment Due to Alzheimer's Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 4, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment48

Start dateApr 2022

Last updatedJul 4, 2025

Condition

Mild Cognitive Impairment Due to Alzheimer's Disease Dementia Due to Alzheimer's Disease (Disorder)

Locations shown

University of the Balearic Islands

Palma, Mallorca, Balearic Islands

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 4, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions